Baris Ugur
Baris Ugur, head of medical, Sanofi Vaccines UK and Ireland
HSJ PartnersHow improved management of Respiratory Syncytial Virus in infants can reduce burden on the NHS
This piece was fully funded, initiated and written by Sanofi.
Close menu
- Home
- Sectors
- Topics
- Local
- Comment
- Interactive
- Events
- Jobs
- Products & Services
- Subscribe
HSJ is part of Wilmington Healthcare Limited. Company number 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Registered in England and Wales. Company registration 30158470
Site powered by Webvision Cloud